CARSTEN BOESS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CARSTEN BOESS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CARSTEN BOESS. CARSTEN BOESS is in ALEXION PHARMACEUTICALS INC ($ALXN) and Vice President & CFO in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Chief Financial Officer in SYNAGEVA BIOPHARMA CORP ($GEVA) and in ROCKET PHARMACEUTICALS, INC. ($RCKT) and Director in INOTEK PHARMACEUTICALS CORP ($ITEK) and 10% Owner in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Latest Insider Trading Transactions of CARSTEN BOESS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, KNSA, RCKT, GEVA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
| Jun 18 2020 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Option Exercise | A | 19.90 | 20,000 | 398,000 | 20,000 | ||
| Jan 30 2019 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Option Exercise | A | 14.56 | 30,000 | 436,800 | 30,000 | ||
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | C | 0.00 | 107,050 | 0 | 473,035 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | C | 0.00 | 6,392 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | C | 0.00 | 107,050 | 0 | 0 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Option Exercise | P | 0.00 | 6,392 | 0 | 6,392 | |
| May 29 2018 | KNSA | Kiniksa Pharmaceut ... | BOESS CARSTEN | 10% Owner | Buy | C | 0.00 | 6,392 | 0 | 79,589 | 73.2 K to 79.6 K (+8.73 %) |
| Apr 02 2018 | RCKT | ROCKET PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 18.75 | 40,000 | 750,000 | 40,000 | |
| Jun 21 2017 | ITEK | INOTEK PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 1.80 | 45,000 | 81,000 | 45,000 | |
| Jun 27 2016 | ITEK | INOTEK PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 7.61 | 12,000 | 91,320 | 12,000 | |
| Jan 12 2016 | ITEK | INOTEK PHARMACEUTI ... | BOESS CARSTEN | Director | Option Exercise | A | 8.89 | 24,000 | 213,360 | 24,000 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 80.35 | 40,000 | 3,214,000 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 40.74 | 15,938 | 649,314 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 40.32 | 45,000 | 1,814,400 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 23.00 | 7,292 | 167,716 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Option Exercise | D | 1.70 | 9,929 | 16,879 | 0 | |
| Jun 23 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Sell | D | 0.00 | 24,000 | 0 | 0 | 24 K to 0 (-100.00 %) |
| Jun 09 2015 | GEVA | SYNAGEVA BIOPHARMA ... | BOESS CARSTEN | SVP, Chief Financia ... | Grant | A | 0.00 | 24,000 | 0 | 24,000 | 0 to 24 K |
| Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 16.10 | 625 | 10,063 | 0 | ||
| Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 16.10 | 625 | 10,063 | 0 | ||
| Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 18.16 | 5,506 | 99,989 | 0 | ||
| Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Option Exercise | M | 18.16 | 4,494 | 81,611 | 0 | ||
| Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Sell | S | 23.47 | 5,000 | 117,350 | 0 | 5 K to 0 (-100.00 %) | |
| Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Sell | S | 23.40 | 3,000 | 70,200 | 0 | 3 K to 0 (-100.00 %) | |
| Jun 29 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Sell | S | 23.27 | 3,250 | 75,628 | 0 | 3.3 K to 0 (-100.00 %) | |
| Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Vice President & CF ... | Option Exercise | A | 20.38 | 6,000 | 122,280 | 6,000 | |
| Mar 11 2005 | ALXN | ALEXION PHARMACEUT ... | BOESS CARSTEN | Vice President & CF ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Page: 1